Company intelligence / Profile preview

Pure Breed

Ownership: Private
Development stage: Commercial

Overview

Pure Breeding specializes in feminized cannabis seed production with a focus on quality control to avoid hermaphroditic plants. The company highlights its work supporting patients using medical marijuana for cancer symptoms, seizures, and chronic pain. There are no clinical trial results as it is not a pharmaceutical developer.

Therapeutic areas: OncologyNeurology
Modalities: Plant-based therapyCannabis-derived productsSmall molecule
Industry: Agriculture & AgTech

Partnerships

Not specified; works with patients directly for medical use of products.

Beyond the preview

Go deeper on Pure Breed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pure Breed.

Explore the full profile